204 related articles for article (PubMed ID: 33615393)
1. The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010-2019.
Alidjanov JF; Cai T; Bartoletti R; Bonkat G; Bruyère F; Köves B; Kulchavenya E; Medina-Polo J; Naber K; Perepanova T; Pilatz A; Tandogdu Z; Bjerklund Johansen TE; Wagenlehner FM
World J Urol; 2021 Sep; 39(9):3423-3432. PubMed ID: 33615393
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
[TBL] [Abstract][Full Text] [Related]
3. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.
Wagenlehner FM; van Oostrum E; Tenke P; Tandogdu Z; Çek M; Grabe M; Wullt B; Pickard R; Naber KG; Pilatz A; Weidner W; Bjerklund-Johansen TE;
Eur Urol; 2013 Mar; 63(3):521-7. PubMed ID: 22704727
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial.
Zembower TR; Maxwell KM; Nadler RB; Cashy J; Scheetz MH; Qi C; Schaeffer AJ
BMC Infect Dis; 2017 Jun; 17(1):401. PubMed ID: 28592230
[TBL] [Abstract][Full Text] [Related]
6. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ
Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of efficacy and complications between transrectal and transperineal prostate biopsy with or without antibiotic prophylaxis.
He J; Guo Z; Huang Y; Wang Z; Huang L; Li B; Bai Z; Wang S; Xiang S; Gu C; Pan J
Urol Oncol; 2022 May; 40(5):191.e9-191.e14. PubMed ID: 35168882
[TBL] [Abstract][Full Text] [Related]
9. Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy.
Recabal P; Lee T; Vertosick E; Manasia M; Eastham J; Touijer K; Seo SK; Spaliviero M; Ehdaie B
World J Urol; 2020 Apr; 38(4):965-970. PubMed ID: 31190154
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy.
Steinberg RS; Kipling L; Bens KCB; Patil D; Henry M; Mehta A; Filson C
World J Urol; 2021 Sep; 39(9):3415-3422. PubMed ID: 33772321
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial.
Jacewicz M; Günzel K; Rud E; Sandbæk G; Magheli A; Busch J; Hinz S; Baco E
Lancet Infect Dis; 2022 Oct; 22(10):1465-1471. PubMed ID: 35839791
[TBL] [Abstract][Full Text] [Related]
13. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
[TBL] [Abstract][Full Text] [Related]
14. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
[TBL] [Abstract][Full Text] [Related]
15. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
Jiang P; Liss MA; Szabo RJ
J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
[TBL] [Abstract][Full Text] [Related]
16. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
[TBL] [Abstract][Full Text] [Related]
17. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
[TBL] [Abstract][Full Text] [Related]
19. [Ecology and fluoroquinolon resistance profiles in febrile urinary tract infections (FUTI) after prostate needle biopsy: A retrospective study in 466 biopsies].
Duboureau H; Achkar K; Stephan R; Schmit JL; Saint F
Prog Urol; 2017 May; 27(6):345-350. PubMed ID: 28478906
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
